OAKVILLE, ON, July 27, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced it will release its Q2 2020 financial results after the close on Wednesday, August 12, 2020.  The Company will hold a conference call on Thursday, August 13, 2020 to discuss the results.  

CONFERENCE CALL DETAILS

DATE: Thursday, August 13, 2020
TIME: 8:30 a.m ET
DIAL-IN: (416) 764-8688 or (888) 390-0546
CONFERENCE ID:      37039570
REPLAY DIAL-IN:     1 (888) 390-0541 (Playback 039570#)
Expires August 20, 2020
Webcast: https://produceredition.webcasts.com/starthere.jsp?ei=1349740&tp_key=fe3acf5205

About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.